Christine Cassiano | Chief Communications Officer |
David Chang | President and Chief Executive Officer |
Rafael Amado | Executive Vice President of Research and Development and Chief Medical Officer |
Eric Schmidt | Chief Financial Officer |
Tyler Van Buren | Cowen |
Michael Schmidt | Guggenheim |
John Newman | Canaccord |
Luca Issi | RBC Capital |
Salveen Richter | Goldman Sachs |
Cory Kasimov | JPMorgan |
Raju Prasad | William Blair |
Mark Breidenbach | Oppenheimer |
Reni Benjamin | JMP Securities |
Asthika Goonewardene | Truist Securities |
Dane Leone | Raymond James |
Kalpit Patel | B. Riley |
David Dai | SMBC |
Hello, thank you for standing by, and welcome to Allogene Therapeutics Third Quarter 2021 Conference Call. At this time, all participant lines are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be aware that today's conference is being recorded. I would now like to hand the conference over to Christine Cassiano, Chief Communications Officer.